BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24590623)

  • 1. Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization.
    Avila ML; Shah PS; Brandão LR
    Cochrane Database Syst Rev; 2014 Mar; (3):CD010196. PubMed ID: 24590623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization.
    Avila ML; Shah PS; Brandão LR
    Cochrane Database Syst Rev; 2020 Feb; 2(2):CD010196. PubMed ID: 32065663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children.
    Pelland-Marcotte MC; Amiri N; Avila ML; Brandão LR
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD005982. PubMed ID: 32557627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet and anticoagulant agents for primary prevention of thrombosis in individuals with antiphospholipid antibodies.
    Bala MM; Paszek E; Lesniak W; Wloch-Kopec D; Jasinska K; Undas A
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012534. PubMed ID: 30004572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparin for prevention of central venous catheterization-related thrombosis in children.
    Brandão LR; Shah N; Shah PS
    Cochrane Database Syst Rev; 2014 Mar; (3):CD005982. PubMed ID: 24615288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interventions for preventing thrombosis in solid organ transplant recipients.
    Surianarayanan V; Hoather TJ; Tingle SJ; Thompson ER; Hanley J; Wilson CH
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD011557. PubMed ID: 33720396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin-bonded catheters for prolonging the patency of central venous catheters in children.
    Shah PS; Shah N
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005983. PubMed ID: 24569952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah P; Shah V
    Cochrane Database Syst Rev; 2005 Jul; (3):CD002772. PubMed ID: 16034876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
    Robertson L; Strachan J
    Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation.
    Lin PT; Wang SH; Chi CC
    Cochrane Database Syst Rev; 2020 Apr; 4(4):CD009894. PubMed ID: 32302004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous heparin infusion to prevent thrombosis and catheter occlusion in neonates with peripherally placed percutaneous central venous catheters.
    Shah PS; Shah VS
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002772. PubMed ID: 18425882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery.
    Di Nisio M; Peinemann F; Porreca E; Rutjes AW
    Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD009658. PubMed ID: 26091835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Home versus in-patient treatment for deep vein thrombosis.
    Othieno R; Okpo E; Forster R
    Cochrane Database Syst Rev; 2018 Jan; 1(1):CD003076. PubMed ID: 29315455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulation for people with cancer and central venous catheters.
    Akl EA; Ramly EP; Kahale LA; Yosuico VE; Barba M; Sperati F; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Oct; (10):CD006468. PubMed ID: 25318061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low molecular weight heparin for prevention of microvascular occlusion in digital replantation.
    Chen YC; Chi CC; Chan FC; Wen YW
    Cochrane Database Syst Rev; 2013 Jul; (7):CD009894. PubMed ID: 23836382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin for prolonging peripheral intravenous catheter use in neonates.
    Shah PS; Ng E; Sinha AK
    Cochrane Database Syst Rev; 2005 Oct; (4):CD002774. PubMed ID: 16235300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin-bonded catheters for prolonging the patency of central venous catheters in children.
    Shah PS; Shah N
    Cochrane Database Syst Rev; 2007 Oct; (4):CD005983. PubMed ID: 17943871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.
    Hamulyák EN; Scheres LJ; Marijnen MC; Goddijn M; Middeldorp S
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012852. PubMed ID: 32358837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients.
    Junqueira DR; Perini E; Penholati RR; Carvalho MG
    Cochrane Database Syst Rev; 2012 Sep; (9):CD007557. PubMed ID: 22972111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.